|
|
Liver transplantation versus liver resection for hepatocellular carcinoma: a meta-analysis |
Xin-Sen Xu, Chang Liu, Kai Qu, Yan-Zhou Song, Peng Zhang and Yue-Lang Zhang |
Xi'an, China
Author Affiliations: Department of Hepatobiliary Surgery (Xu XS, Liu C, Qu K, Song YZ and Zhang P) and Department of Radiology (Zhang YL), First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, China
Corresponding Author: Chang Liu, MD, PhD, Department of Hepatobiliary Surgery, First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, China (Tel: 86-29-85323900; Fax: 86-29-82654746; Email: liuchangdoctor@163.com) |
|
|
Abstract BACKGROUND: Liver transplantation (LT) and liver resection (LR) are currently considered the standard treatment of patients with hepatocellular carcinoma (HCC). However, the outcomes of LT and LR are still inconclusive.
DATA SOURCES: MEDLINE, EMBASE, and Cochrane Library were searched for relevant studies. Surgical safety indices such as treatment-related morbidity and mortality, and efficacy indices such as overall and tumor-free survival outcomes were evaluated. Weighted mean differences and odds ratios (ORs) were calculated using a random-effects model.
RESULTS: Seventeen studies were included in this meta-analysis. LT achieved significantly higher rates of surgery-related morbidity (OR=1.47; 95% CI: 1.02-2.13) and mortality (OR=2.12; 95% CI: 1.11-4.05). Likewise, the 1-year survival rate was lower in LT (OR=0.86; 95% CI: 0.61-1.20). However, the 3- and 5-year survival rates were significantly higher in LT than in LR and the ORs were 1.12 (95% CI: 0.96-1.30) in 3 years and 1.84 (95% CI: 1.49-2.28) in 5 years. Furthermore, the tumor-free survival rate in LT was significantly higher than that in LR in 1, 3, 5 years after surgery, with the ORs of 1.72 (95% CI: 1.24-2.41), 3.75 (95% CI: 2.94-4.78) and 5.64 (95% CI: 4.35-7.31), respectively.
CONCLUSIONS: One-year morbidity and mortality are higher in LT than in LR for patients with HCC. However, long-term survival and tumor-free survival rates are higher in patients treated with LT than those treated with LR.
|
|
|
|
|
|
|
|